Citation Tools

Download PDFPDF

622 PD-L1 is a potential predictive biomarker for response to RM-1929 treatment in recurrent head and neck squamous cell carcinoma patients

Download to a citation manager

Cite this article as:
De Magalhaes Filho CD, Lee C, Suslov N, et al
622 PD-L1 is a potential predictive biomarker for response to RM-1929 treatment in recurrent head and neck squamous cell carcinoma patients